Effectiveness of 3D Bone Matrix in Cranioplasty
Launched by UNIVERSIDAD AUSTRAL DE CHILE · Jan 23, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study will be a parallel-arm clinical trial (8 patients randomly divided into 2 groups), where the participants will be patients with cranial defects requiring cranioplasty at the Department of Neurosurgery of Base Hospital of Valdivia, Chile. Previously, data of each participant will be collected, such as sex, age, basic comorbidities and clinical diagnosis.
The outcome variables to be considered in this study are: The volume of bone reconstruction measure in axial computed tomography (CT) using the tool available in Mimics software delivering the value in cm3 , and the scaffold attac...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients between 18 and 70 years of age, with acquired skull defect from neurological surgeries such as:
- • craniocerebral trauma,
- • refractory intracranial arterial hypertension,
- • congenital cranial defects such as hydrocephalus or other similar surgically resolvable defects,
- • who are suitable for reconstruction using a PCL-TCP scaffold system;
- • patients or their guardians are capable of giving valid informed consent.
- Exclusion Criteria:
- • Active infection at the time of study inclusion (in cases of chronic infection, active infections may manifest as a result of a failed trial of antibiotic withdrawal),
- * immunodeficiency such as:
- • HIV,
- • systemic corticosteroid therapy,
- • chemotherapy,
- • synchronous hematologic malignancy,
- • other causes of secondary or primary immunodeficiency;
- • patients with uncontrolled chronic diseases such ascardiovascular, respiratory or immunological diseases,
- • psychiatric disorders not controlled with home pharmacotherapy,
- • Women currently pregnant, breastfeeding or planning to become pregnant within 2 years of reconstruction surgery,
- • patients with a life expectancy of less than 12 months.
About Universidad Austral De Chile
Universidad Austral de Chile is a leading academic institution dedicated to advancing scientific research and innovation in various fields, including healthcare. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient outcomes and contributing to medical knowledge. Its commitment to ethical standards and rigorous scientific methodologies ensures that research conducted under its auspices adheres to the highest quality benchmarks, fostering advancements in clinical practice and public health. Through its clinical trial initiatives, Universidad Austral de Chile aims to enhance the understanding of disease mechanisms and treatment efficacy, ultimately benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valdivia, , Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported